MedPath

Evaluation of pegaptanib and ranibizumab for macular edema secondary to retinal vein occlusio

Not Applicable
Recruiting
Conditions
macular edema secondary to retinal vein occlusion
Registration Number
JPRN-UMIN000002012
Lead Sponsor
Yamagata university,Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

The patients with good visual acuity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath